Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years

Turner's Syndrome Clinical Trial

Official title:
Collaborative Study to Assess the Effects of Treatment With Recombinant Growth Hormone Saizen® in the Prevention of Short Stature in Young Girls Suffering From Turner Syndrome Before the Age of 4 Years. Original French Title: Etude Collaborative Pour apprécier Les Effets du Traitement Par l'Hormone de Croissance Recombinante SAIZEN® Dans le Retard de Croissance de la Fillette Atteinte de Syndrome de Turner Avant l'âge de 4 Ans

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the efficacy and safety of recombinant human growth hormone (r-hGH) treatment in girls with Turner Syndrome under the age of 4 years. After 4 years of treatment, height in these girls will be compared with an historical control group of untreated girls with Turner Syndrome, matched for age and height at baseline.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01066052
Study type	Interventional
Source	Merck KGaA, Darmstadt, Germany
Contact
Status	Completed
Phase	Phase 4
Start date	February 29, 1992
Completion date	August 31, 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00006334` - Turner Syndrome: Genotype and Phenotype	N/A
Not yet recruiting	`NCT02871986` - Pubertal Induction in Individuals With Hypogonadism	N/A
Completed	`NCT01306357` - Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device
Completed	`NCT00001221` - Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome	Phase 2
Completed	`NCT00250250` - An Open-Label, Multi-centre, Phase III Study of Local Tolerability of ZOMACTON 10MG	Phase 3
Completed	`NCT00004275` - Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome	Phase 2
Completed	`NCT00001253` - The Effects of Estrogen on Cognition in Girls With Turner Syndrome	Phase 2
Completed	`NCT00013546` - Hormone Replacement Therapy to Treat Turner Syndrome	Phase 2
Terminated	`NCT02018172` - Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X Device	N/A
Completed	`NCT01813630` - A Clinical Study to Assess the Efficacy and Safety of DA-3002	Phase 3
Completed	`NCT00004274` - Effect of Estrogen on Mental and Social Functioning in Girls With Turner's Syndrome	N/A
Completed	`NCT00001343` - The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome	Phase 2
Terminated	`NCT00870220` - Initiating Transdermal Estradiol Therapy in Turner's Syndrome	Phase 1